ClearPoint Neuro, Inc. (CLPT)
NASDAQ: CLPT · IEX Real-Time Price · USD
5.30
-0.03 (-0.56%)
Jul 2, 2024, 4:00 PM EDT - Market closed
ClearPoint Neuro Market Cap
ClearPoint Neuro has a market cap or net worth of $145.33 million as of July 2, 2024. Its market cap has decreased by -11.11% in one year.
Market Cap
145.33M
Enterprise Value
123.87M
1-Year Change
-11.11%
Ranking
Category
Stock Price
$5.30
Market Cap Chart
Since May 22, 2012, ClearPoint Neuro's market cap has increased from $30.30M to $145.33M, an increase of 379.63%. That is a compound annual growth rate of 13.81%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 2, 2024 | 145.30M | -13.10% |
Dec 29, 2023 | 167.20M | -19.62% |
Dec 30, 2022 | 208.00M | -21.57% |
Dec 31, 2021 | 265.20M | -1.08% |
Dec 31, 2020 | 268.10M | 267.26% |
Dec 31, 2019 | 73.00M | 337.13% |
Dec 31, 2018 | 16.70M | -41.61% |
Dec 29, 2017 | 28.60M | 132.52% |
Dec 30, 2016 | 12.30M | -56.84% |
Dec 31, 2015 | 28.50M | -41.84% |
Dec 31, 2014 | 49.00M | -42.22% |
Dec 31, 2013 | 84.80M | 10.42% |
Dec 31, 2012 | 76.80M | 153.47% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
TruBridge | 150.07M |
TriSalus Life Sciences | 149.92M |
Atossa Therapeutics | 149.65M |
Quantum-Si incorporated | 148.91M |
Caribou Biosciences | 148.12M |
Elevation Oncology | 147.52M |
InfuSystem Holdings | 145.45M |
Acumen Pharmaceuticals | 145.39M |